Fungal bioconversions: Applications to the manufacture of pharmaceuticals

Handbook of Industrial Mycology

Volumn , Issue , 2004, Pages 563-596

  Chartrain, Michel ^a   Sturr, Michael ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57249112278     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203970553     Document Type: Chapter

References (127)

1. Caldwell, J.A.H.; Fournel-Gigleux, S. “The metabolic chiral inversion and dispositional enantioselectivity of the 2-aryl-proprionic acids and their biological consequences.” Biochemical Pharmacology 1988, 37, 105-114.
2. Handley, D.; Tinkelman, D.; Noonan, M.; Rollins, T.; Snider, M.; Caron, J. “Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.” Journal of Asthma 2000, 37 (4), 319-327.
3. Ariens, E. “Nonchiral, homochiral and composite chiral drugs.” TIBS 1993, 14, 68-86.
4. Rauws, A.; Roen, K. “Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States.” Chirality 1994, 6, 72-75.
5. Stinson, S. “Fertile ferment in chiral chemistry.” C&EN 2000, (May 8), 59-70.
6. Stinson, S. “Chiral pharmaceuticals.” C&EN 2001, (October 1), 79-97.
7. Stinson, S. “Chiral drug market shows signs of maturity.” C&EN 1997, (October 1997), 38-70.
8. Jones, B. “Enzymes in orgnic synthesis.” Tetrahedron 1986, 42, 3351-3403.
9. Yeh, W. “Evolving enzyme technology for pharmaceutical applications:case studies.” J. Indust. Microbiol. 1997, 19, 334-343.
10. Zaks, A.; Dodds, D. “Applications of biocatalysis and biotransformations to the synthesis of pharmaceuticals.” DDT 1997, (2), 513-531.
11. Zaks, A. “Industrial biocatalysis.” Curr. Opn. Chem. Biol. 2001, 5, 130-136.
12. Leuenberger, H.; Matzinger, P.; Wirz, B. “Synthesis and metabolism of drugs by means of enzyme-catalyzed reactions.” Chimia 1999, 53, 536-540.
13. Mahmoudian, M. “Biocatalytic production of chiral pharmaceutical intermediates.” Biocatalysis and Biotransformation 2000, 18, 105-118.
14. Patel, R. Encyclopedia of Microbiology. Academic Press: New York, 2000; Vol. 1, 430-444.
15. Anastas, P.; Kirchoff, M.; Williamson, T. “Catalysis as a foundational pillar of green chemistry.” Applied Catalysis A: General 2001, 221, 3-13.
16. Davies, H.; Green, R.; Kelly, D.; Roberts, S. Biotransformations in preparative organic chemistry: The use of isolatated enzymes and whole cells systems in shynthesis. Academic Press: London, 1989.
17. Collins, A.; Sheldrake, G.; Crosby, J. Chirality in industry: The commercial manufacture and applications of optically active compounds. J. Wiley and Sons: Chichester, 1992.
18. Cabral, J.; Best, D.; Boross, L.; Tramper, J. Applied biocatalysis. Harwood Academic Pub: Chur, 1994.
19. Azerad, R. “Microbial models for drug metabolism.” Advances in Biochemical Engineering/Biotechnology 1999, 63, 169-218.
20. Kieslish, K. “Biotransformations of industrial use.”. Acta Biorechnol. 1991, 6, 559-570.
21. Leuenberger, H.; Wirz, B. “Biotransformation leading to optically active synthons for the preparation of fine chemicals.” Chimia 1993, 47, 82-85.
22. Roberts, S. “The growing use of bio-oxidation reactions for the preparation of chiral organic chemicals.” The Genetic Engineer and Biotechnologist 1993, 13, 61-74.
23. Roberts, S.; Turner, N.; Willets, A.; Turner, M. Introduction to biocatalysis using enzymes and micro-organisms. Cambridge University Press: Cambridge, 1995.
24. Roberts, S.; Williamson, N. “The use of enzymes for the preparation of biologically active natural products and analogs in optically active form.” Curr. Org. Chem. 1997, 1, 1-20.
25. Wong, C.; Whitesides, G. Enzymes in synthetic organic chemistry. Elsevier: Oxford, 1994.
26. Turner, M. “Biocatalysis in organic chemistry (part II): present and future.” Trends in Biotechnol. 1995, 13, 253-258.
27. Holland, H. “Microbial transformations.” Curr. Opn. Chem. Biol. 1998, 2, 77-84.
28. Liese, A.; Filho, M. “Production of fine chemicals using biocatalysis.” Curr. Op. Biotechnol. 1999, 10, 595-603.
29. Rozzell, D. “Commercial scale biocatalysis: myths and realities.” Bioorganic and Medicinal Chemistry 1999, 7, 2253-2261.
30. Schulze, B.; Wubbolts, M. “Biocatalysis for industrial production of fine chemicals.” Curr. Op. Biotechnol. 1999, 10, 609-615.
31. Faber, K. Biotransformations in Organic Chemistry. Springer-Verlag: Berlin Heidelberg New York, 2000.
32. Patel, R. Stereoselective Biocatalysis. Macel Dekker, Inc: New York, NY, 2000.
33. Wandrey, C.; Liese, A.; Kihumbu, D. “Industrial biocatalysis: past, present, and future.” Organic Process Res. Dev. 2000, 4, 286-290.
34. Schmid, A.; Dordick, J.; Hauer, B.; Kiener, M.; Wubbolts, M.; Witholt, B. “Industrial biocatalysis today and tomorrow.” Nature 2001, 409, 258-268.
35. Peterson, D.; Murray, H.; Epstein, S.; Reineke, L.; Weintaub, A.; Meister, P.; Leigh, H. “Microbiological transformations of steroids. I. Introduction of oxygen at carbon-11 of progesterone.” J. Am. Chem. Soc. 1952, 74, 5933-5936.
36. Marshall, V.; Wiley, P. Microbial transformations of antibiotics. CRC: Boca Raton, 1982.
37. Sebek, O. Biotechnology. Kieslish, K., Ed. Verlag Chemie: Weinheim, 1984; Vol. 6A, 239-276.
38. Charney, W.; Herzog, H. Microbial transformation of steroids, a handbook. Academic Press: New York, 1967.
39. Sedlaczek, L. “Biotransformations of steroids.” Critical Rev. Biotechnol. 1988, 7, 187-236.
40. Smith, L. Steroids. Verlag Chemie: Weinheim, 1984.
41. Davis, P. Biotechnology. Kieslish, K., Ed. Verlag Chemie: Weinhiem, 1984; Vol. 6A, 207-238.
42. Holland, H. Biotechnology of filamentous fungi. Technology and products. Finkelstein, D., Ball, C., Eds. Butterworth-Heinemann: Boston, 1992; 157-187.
43. de Bont, J. “Bioformation of optically pure epoxides.” Tetrahedron Asymmetry 1993, 4, 1331-1340.
44. Fransen, M. “Halogenation and oxididation reactions with haloperoxidases.” Biocatalysis 1994, 10, 87-111.
45. Fransen, M. “Haloperoxidases: useful catalysts for halogenation and oxidation reactions.” Catalysis Today 1994, 22, 441-457.
46. Archelas, A.; Furstoss, R. “Biocatalytic approaches for the synthesis of enantiopure epoxides.” Top. Curr. Chemistry 1999, 200, 159-191.
47. Fang, J.; Lin, C.; Bradshaw, C.; Wong, C. “Enzymes in organic synthesis: oxidoreductions.” J. Chem. Soc. Perkin Trans. 1995, 1, 967-978.
48. Holland, H. “Recent Advances in applied and mechanistic aspects of the enzymatic hydroxylation of steroids by whole-cell biocatalysts.” Steroids 1999, 64, 178-186.
49. Holland, H.; Weber, H. “Enzymatic hydroxylation reactions.” Cur. Op. Biotechnol. 2000, 11 (6), 547-553.
50. Roberts, S.; Wiggins, K.; Casy, G.; Phythian, S. Preparative biotransformations. Whole cell and isolated enzymes in organic synthesis. John Wiley and Sons: Chichester, 1993.
51. Banerjee, A. Stereoselective Biocatalysis. Patel, R., Ed. Macel Dekker: New York, N.Y., 2000.
52. Holland, H. “Chiral sulfoxidation by biotransformation of organic sulfides.” Chem. Rev. 1988, 88, 473-485.
53. Nakamura, K.; Kawai, Y.; Kitayama, T.; Ogawa, M.; Mikata, Y.; Higaki, M.; Ohno, A. “Asymmetric reduction of ketones with microbes.” Bull. Inst. Chem. Res. Kyoto Univ. 1989, 67, 157-168.
54. Chartrain, M.; Lynch, J.; Choi, W.-B.; Churchill, H.; Patek, S.; Yamazaki, S.; Volante, R.; Greasham, R. “Asymmetric bioreduction of a bisaryl ketone to its corresponding (S)-bisaryl alcohol, by the yeast Rhodotorula pilimanae ATCC 32762.” J. Mol. Catal. B: Enzymatic 2000, 8, 285-288.
55. Stewart, J. “Dehydrogenases and transaminases in asymmetric synthesis.” Cur. Op. Chem. Biol. 2001, 5, 120-129.
56. Fransen, M.; van der Plas, H. “Haloperoxidases: their properties and their use in organic synthesis.” Adv. Appl. Microbiol. 1992, 37, 41-98.
57. Colonna, S.; Gaggero, N.; Richelmi, C.; Pasta, P. “Recent biotechnological developments in the use of peroxidases.” TIBTECH 1999, 17, 163-168.
58. Zaks, A.; Dodds, D. “Chloroperoxidase-catalyzed asymmetric oxidations: substrate specificity and mechanistic study.” J. Am. Chem. Soc. 1995, 117, 10419-10424.
59. Pesti, J.; Dicosimo, R. “Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates.”. Curr. Op. Drug Discov. Dev. 2000, 3, 764-782.
60. Mischitz, M.; Koutil, W.; Wandel, U.; Faber, K. “Asymmetric hydrolysis of epoxides.” Tetrahedron: Asymm. 1995, 6, 1261-1272.
61. Archelas, A.; Furstoss, R. “Synthesis of enantiopure epoxides through biocatalytic approaches.” Annu. Rev. Microbiol. 1997, 51, 491-525.
62. Archelas, A. “Fungal epoxide hydrolases: new tools for the synthesis of enantiopure epoxides and diols.” Journal of Molecular Catalysis B: Enzymatic 1998, 5 (1-4), 79-85.
63. Archer, I. “Epoxide hydrolases as asymmetric catalysts.” Tetrahedron 1997, 53, 15617-15662.
64. Swaving, J.; deBont, J. “Microbial transformation of epoxides.” Enz. Microbiol. Technol. 1998, 22, 19-26.
65. Steinreiber, A.; Faber, K. “Microbial epoxide hydrolases for preparative biotransformations.” Curr. Op. Biotechnol. 2001, 12, 552-558.
66. Halpern, M. Industrial enzymes from microbial sources. Noyes Data Corporation: Park Ridge, NJ, 1981.
67. Arnold, F.; Volkov, A. “Directed evolution of biocatalysts.” Curr. Opin. Chem. Biol. 1999, 3, 54-59.
68. Farinas, E.; Bulter, T.; Arnold, F. “Directed enzyme evolution.” Current Opinion in Biotechnology 2001, 12 (6), 545-551.
69. Stemmer, W. “Molecular Breeding of genes, pathways, and genomes by DNA shuffling.” J. Molecular Catalysis B: Enzymatic 2002, 19, 3-12.
70. Weijers, C.; de Bont, J. “Epoxide hydrolases from yeasts and other sources: versatile tools in biocatalysis.” J. Mol. Catal. B: Enzymatic 1999, 6, 199-214.
71. Dalboge, H.; Lange, L. “Using molecular techniques to identify new microbial catalysts.” Trends in Biotechnol. 1998, 16, 265-272.
72. Sakuradani, E.; Kobayashi, M.; Shimizu, S. “Fatty Acid desaturase from an arachidonic acidproducing Mortierella fungus: Gene cloning and its heterologous expression in a fungus, Aspergillus.” Gene 1999, 238, 445-453.
73. Gihani, M.; Williams, J. “Dynamic Kinetic Resolution.” Cur. Op. Chem. Biol. 1999, 3, 11-15.
74. Adlercreutz, P. Biocatalysis in non-conventional media. Applied Biocatalysis. Cabral, J., Best, D., Boross, L., Tramper, J., Eds. Harwood Academic Publishers: Chur, 1994.
75. Hunter-Cevera, J.; Sotos, L. “Screening for a “new” enzyme in nature: haloperoxidase production by Death Valley dematiaceous hyphomycetes.” Microbiol. Ecol. 1986, 12, 121-127.
76. Nurika, M.; Ito, S.; Kurebayashi, T. “Microbial transformation of indene by the Pyricularia zingiberi Nishikado fungus.” Biosci. Biotech. Biochem. 1996, 60, 2097-2098.
77. Buckland, B.; Drew, S.; Connors, N.; Chartrain, M.; Lee, C.; Salmon, P.; Gbewonyo, K.; Zhou, W.; Gailliot, P.; Singhvi, R.; Olewinski, R.; J-Sun, W.; Reddy, J.; Zhang, J.; Jackey, B.; Taylor, C.; Goklen, K.; Junker, B.; Greasham, R. “Microbial conversion of indene to indandiol: a key intermediate in the synthesis of Crixivan.” Met. Eng. 1999, 1, 63-74.
78. Cerneglia, C. “Fungal metabolism of polycyclic aromatic hydrocarbons: past, present and future applications in bioremediations.” J. Indus. Microbiol. 1997, 19, 324-333.
79. Rodriguez, S.; Kayser, M.; Stewart, J. “Highly stereoselective reagents for beta-keto ester reductions by genetic engineering of baker’s yeast.” J.O.A.C.S. 2001, 123, 1547-1555.
80. Patel, R.; Banerjee, A.; McNamee, C.; Szarka, L. “Stereoselective microbial reduction of N- 4(1-oxo-2-chloroacetyl ethyl) phenyl methane sulfonamide.” Appl. Microbiol. Biotechnol. 1993, 40, 241-245.
81. Chartrain, M.; Armstrong, J.; Katz, L.; Keller, J.; Mathre, D.; Greasham, R. “Asymmetric bioreduction of a beta-ketoester to (R)-beta hydroxyester by the fungus Mortierella alpina MF5534.” J. Ferm. and Bioeng. 1995, 80 (2), 176-179.
82. Roy, S.; Alexandre, V.; Neuwels, M.; Le Texier, L. “Asymmetric bioreduction of a bulky ketone: 1-Phenyl-1-(2-phenyl-thiazolyl-5-yl)-methanone.” Advances Synthesis & Catalysis 2001, 343, 738-743.
83. Patel, R.; Banerjee, A.; Liu, M.; Hanson, R.; Ko, R.; Howell, J.; Szarka, L. “Microbial reduction of 1-(4-fluorophenyl)-4-[4-5-fluor-2-pyrimidinylo-1-piperazinyl]butan-1-one.” Biotechnol. Appl. Biochem. 1993, 17, 139-153.
84. Blackner, A.; Holt, R. Development of a multi-stage chemical and biological process for an optically active intermediate for an anti-glaucoma drug. Chirality in industry. Collins, A., Sheldrake, G., Crosby, J., Eds. 1997; 245-261.
85. Patel, R.; Howell, J.; McNamee, C.; Fortney, L. Szarka, K. “Stereoselective enzymatic hydrolysis of alpha-[(acetylthio)methyl]-benzenepropanoic acid and 3-acetylthio-methylpropanoic acid.” Biotechnol. Appl. Biochem. 1992, 16, 34-47.
86. Sidler, D.; Chartrain, M.; Ikemoto, N.; Bills, G.; Roberge, C.; Taylor, C. Enzymatic Process of making alpha 1a adrenergic receptor anatagonsits using protease. United States Patent, 2001.
87. Sidler, D.; Barta, N.; Li, W.; Hu, E.; Matty, L.; Ikemoto, N.; Campbell, J.; Chartrain, M.; Gbewonyo, K.; Boyd, R.; Corley, E.; Ball, R.; Larsen, R.; Reider, P. “Efficient synthesis of the optically active dihydropyrimidinone of a potent alpha 1a selective adrenoreceptor antagonist.” Can. J. Chem. 2002, 80, 646-652.
88. Sakaguchi, K. a. S. M. “A preliminary report on a new enzyme, Penicillin amidase.” J. Agric. Chem. Soc. Jpn. 1950, 23, 411-414.
89. Pedragosa-Moreau, S.; Morisseau, C.; Baratti, J.; Zylber, J.; Archelas, A.; Furstoss, R. “Microbiological transformations 37: An enantioconvergent synthesis of the beta-blocker (R)- nifenalol using a combined chemoenzymatic approach.” Tetrahedron 1997, 53, 28-32.
90. Sih, C.; Gu, Q.; Fulling, G.; Wu, S.; Reddy, D. “The use of microbial enzymes for the synthesis of optically active pharmaceuticals.” Dev. Indus. Microbiol. 1988, 29, 221-229.
91. Patel, R.; Banerjee, A.; Davis, B.; Howell, J.; McNamee, C.; Brzozowski, D.; North, J.; Kronenthal, D.; Szarka, L. “Stereoselective epoxidation of 2,2-dimethyl-2H-1-benzopyran- 6-carbonitrile.” Bioorganic. Med. Chem. 1994, 2, 535-432.
92. Zhang, J.; Roberge, C.; Reddy, J.; Connors, N.; Chartrain, M.; Buckland, B.; Greasham, R. “Bioconversion of indene to trans-2S,1S-bromoindnadol and 1S,2R-indene oxide by a bromoperoxidase/dehydrogenase preparation from Curvularia protubertata.” Enz. Microbiol. Tech. 1999, 24, 86-95.
93. Hosobuchi, M.; Yoshikawa, H. Scale-up of microbial processes. Manual of Industrial Microbiology and Biotechnology. Demain, A., Davies, J., Eds. ASM Press: Washington, DC, 1999.
94. Connors, N. Culture medium optimization and scale-up for microbial fermentations. Handbook of Industrial cell culture: Mammalian, Microbial, and Plant Cells. Vinci, V., Parekh, S., Eds. Humana Press Inc: Totowa, NJ, 2002.
95. Vinci, V.; Byng, G. Strain improvement by nonrecombinant methods. Industrial Microbiology and Biotechnology. Demain, A., Davies, J., Eds. ASM Press: Washington, DC, 1999.
96. Bulter, T.; Alcalde, M.; Sieber, V.; Meinhold, P.; Schlachtbauer, C.; Arnold, F. “Functional expression of a fungal laccase in Saccharomyces cerevisiae by directed evolution.” Appl. Environ. Microbiol. 2003, 69 (2), 987-995.
97. Wiseman, A. Handbook of Enzyme Biotechnology. Second edition; Ellis Horwood Limited: Chichester, 1985.
98. Cagnon, J.; Marsaioli, A.; Riatto, V.; Pili, R.; Manfio, G.; Eguchi, S. “Microbial screening for the enantiospecific production of alkyl esters of 4-chloro-3-hydrobutanoic acid.” Chemosphere 1999, 38 (10), 2243-2246.
99. Hunter-Cevera, J.; Belt, A. Isolation of cultures. Manual of Industrial Microbiology and Biotechnology. Demain, A., Davies, J., Eds. ASM Press: Washington, DC, 1999; Vol. 1, 3-20.
100. Atlas, R.; Parks, L. Handbook of Microbiological Media. CRC Press: Boca Raton, 1993.
101. Alexander, M.; Daggett, R.; Gherna, S.; Joung, R.; Simione, F. American Type Culture Collection Methods. M. Hatt. Rockville: MD ATCC.1, 1980; 1-51.
102. Monaghan, R.; Gagliardi, M.; Streicher, S. Culture preservation and inoculum development. Manual of industrial microbiology and biotechnology. Demain, A., Davies, J., Eds. ASM Press: Washington, DC, 1999; Vol. 1, 29-48.
103. Smith, R.; Rosazza, J. Microbial transformations as a mean of preparing mammalian drug metabolites. CRC Press Inc: Boca Raton, FL, 1982.
104. Byng, G.; Preisig, C. “Microbial diversity and the search for new biocatalyts.” Med. Fac. Landbouww. Univ. Gent. 1998, 63/4a, 1247-1252.
105. Petuch, B.; Arison, B.; Dumont, F.; Monaghan, R.; Chen, T. “Microbial transformation of immunosuppressive compounds III. Glucosylation of Immunomycin (FR 900520) and FK 506 by Bacillus subtilis ATCC 55060.” J. Indust. Microbiol. 1994, 13, 131-135.
106. Cardenas, F.; Alvarez, E.; de Castro-Alvarez, M.-S.; Sanchez-Montero, J.-M.; Valmaseda, M.; Elson, S.; Sinisterra, J.-V. “Screening and catalytic activity in organic synthesis of novel fungal and yeast lipases.” J. Mol. Catal. B: Enzymatic 2001, 14, 111-123.
107. Chen, T.; Li, X.; Petuch, B.; Shafiee, A.; So, L. “Structural modification of the immunosuppressant FK 506 and ascomycin using a biological approach.”. Chimia 1999, 53, 596-600.
108. Ogawa, J.; Shimizu, S. “Microbial enzymes: new industrial applications from traditional screening methods.” T.I.B. 1999, 17, 13-21.
109. Goodhue, C. The methodology of microbial transformation of organic compounds. Microbial Transformations of Bioactive Compounds. Rosazza, J., Ed. CRC Press, Inc.: Boca Raton, FL, 1982; Vol. 1, 10-44.
110. Zelinski, T.; Kula, M. “Asymmetric enzymatic reduction of lipophilic ketones in aqueous solution containing cyclodextrins.” Biocatalysis and Biotransformation 1997, 15, 57-74.
111. Chartrain, M.; Greasham, R.; Moore, J.; Reider, P.; Robinson, D.; Buckland, B. “Asymmetric bioreductions: applications to the synthesis of pharmaceuticals.” J. Mol. Catal. B: Enzymatic 2001, 11, 503-512.
112. Nassenstein, A.; Hemberger, J.; Schwartz, H.; Kula, M. “Studies on the enzymatic reduction of N-Boc-4S-amino-3-oxo-5-phenylpentanoic acid methylester.” J. Biotechnol. 1992, 26, 183-201.
113. Vezina, C.; Sehgal, S.; Singh, K. “Transformation of organic compounds by fungal spores.” Adv. Appl. Microbiol. 1968, 10, 221-268.
114. Schmauder, H.; Schlosser, D.; Gunther, T.; Hattenbach, A.; Sauerstein, J.; Jungnicked, F.; Augsten, H. “Applications of immobilized cells for biotransformations of steroids.” J. Basic Microbiol. 1991, 31, 453-477.
115. Mahato, S.; Garai, S. “Advances in microbial steroid biotransformation.” Steroids 1997, 62, 332-345.
116. Duetz, W.; Witholt, B. “Effectiveness of orbital shaking for the aeration of suspended bacterial cultures in square-deepwell microtiter plates.” J. Biochem. Eng. 2001, 7 (2), 113-115.
117. Lye, G.; Parviz, A.; Frank, B.; Dalby, P.; Woodley, J. “Accelerated design of bioconversion processes using automated microscale processing techniques.” T.I.B. 2003, 21 (1), 29-37.
118. Stahl, S.; Greasham, R.; Chartrain, M. “Implementation of a rapid microbial screening procedure for biotransformation activities.” J. Biosc. Bioeng. 2000, 89, 367-371.
119. Wahler, D.; Reymond, J.-L. “Novel methods for biocatalyst screening.” Current Opin. in Chem. Biol. 2001, 5, 152-158.
120. Clausen, I. “Aspects in lipase screening.” J. Mol. Catal. B: Enzymatic 1997, 3, 139-146.
121. Demirjan, D.; Reymond, P.S.; Moris-Varas, F. “Screening for novel enzymes.” Topics in Current Chemistry 1999, 200, 1-29.
122. Taylor, S.; Brown, R.; Keene, P.; Taylor, I. “Novel screening methods. The key to cloning commercially successful biocatalysts.” Bioorganic and Medicinal Chemistry 1999, 7, 2163-2168.
123. Miao, V.; Coeffet-LeGal, M.-F.; Brown, D.; Sinnemann, S.; Donaldson, G.; Davies, J. “Genetic approaches to harvesting lichen products.” TIBS 2001, 19, 349-365.
124. Robertson, D.; Mathur, E.; Swanson, R.; Marrs, B.; Short, J. “The discovery of new biocatalysts from microbial diversity.” SIM news 1996, 46, 3-8.
125. Marrs, B.; Delagrave, S.; Murphy, D. “Novel approaches for discovering industrial enzymes.” Curr. Opn. Microbiol. 1999, 2, 241-245.
126. Zhang, J.; Reddy, J.; Roberge, C.; Senanayake, C.; Greasham, R.; Chartrain, M. “Chiral bioresolution of racemic indene oxide by fungal epoxide hydrolases.” J. Ferm. and Bioeng. 1995, 80, 244-246.
127. Chien, M.; Rosazza, J. “Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxyellipticines.” Drug Metabolism and Disposition 1979, 7, 211-214.